At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
ATNF 180 Life Sciences Corp
Market Closed 12-20 16:00:00 EST
1.86
-0.08
-4.12%
盘后1.83
-0.03-1.61%
19:22 EST
High2.02
Low1.86
Vol54.55K
Open1.98
D1 Closing1.94
Amplitude8.25%
Mkt Cap3.68M
Tradable Cap3.42M
Total Shares1.98M
T/O107.25K
T/O Rate2.97%
Tradable Shares1.84M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
BRIEF-180 Life Sciences Corp - On Dec 16, Omar Jimenez Resigns As CFO Of 180 Life Sciences
180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed Phase IIb clinical trials that focuses on fibrosis and anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. 180 Life Sciences Corp. is headquartered in Palo Alto, California.